Lipocine Inc. (LPCN) DCF Valuation

Lipocine Inc. (LPCN) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Lipocine Inc. (LPCN) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Whether you're an investor or analyst, this Lipocine Inc. (LPCN) DCF Calculator is your essential tool for accurate valuation. Equipped with real data from Lipocine, you can adjust forecasts and immediately observe the effects.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .2 .0 16.1 .5 -2.9 -.7 -.2 .0 .0 .0
Revenue Growth, % 0 -100 0 -96.9 -670.16 -74.23 -74.23 -74.23 -74.23 -74.23
EBITDA -12.6 -18.0 -.4 -10.7 -16.3 .0 .0 .0 .0 .0
EBITDA, % -7666.19 100 -2.67 -2144.28 572.56 -0.53346 -0.53346 -0.53346 -0.53346 -0.53346
Depreciation .0 .0 .0 .0 .0 -.2 .0 .0 .0 .0
Depreciation, % 9.36 100 0.00235428 1.89 -1.01 22.05 22.05 22.05 22.05 22.05
EBIT -12.7 -18.0 -.4 -10.7 -16.4 .0 .0 .0 .0 .0
EBIT, % -7675.55 100 -2.67 -2146.17 573.57 -0.53393 -0.53393 -0.53393 -0.53393 -0.53393
Total Cash 14.1 19.7 44.6 32.5 22.0 -.4 -.1 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .2 .7 .1
Account Receivables, % 10.01 100 1.53 131.97 -1.83
Inventories 5.0 5.0 .0 .0 .0 -.3 -.1 .0 .0 .0
Inventories, % 3030.49 100 0 0.0002 0 40 40 40 40 40
Accounts Payable 1.2 1.6 1.3 .6 1.4 -.4 -.1 .0 .0 .0
Accounts Payable, % 716.55 100 7.99 120.08 -48.97 51.8 51.8 51.8 51.8 51.8
Capital Expenditure .0 .0 .0 -.1 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 0 100 -0.04702978 -26.77 0.46187 -5.36 -5.36 -5.36 -5.36 -5.36
Tax Rate, % -0.00461736 -0.00461736 -0.00461736 -0.00461736 -0.00461736 -0.00461736 -0.00461736 -0.00461736 -0.00461736 -0.00461736
EBITAT -12.7 -18.0 -.4 -10.7 -16.4 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -16.5 -17.6 4.0 -12.0 -14.9 -1.2 -.2 -.1 .0 .0
WACC, % 10.05 10.05 10.05 10.05 10.05 10.05 10.05 10.05 10.05 10.05
PV UFCF
SUM PV UFCF -1.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -5
Equity Value 3
Diluted Shares Outstanding, MM 5
Equity Value Per Share 0.64

What You Will Get

  • Real LPCN Financial Data: Pre-filled with Lipocine Inc.’s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Lipocine Inc.’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Customizable Financial Inputs: Adjust essential parameters such as revenue projections, operating margins, and research & development expenses.
  • Instant DCF Valuation: Quickly computes intrinsic value, net present value (NPV), and other financial metrics.
  • High-Precision Results: Leverages Lipocine Inc.'s (LPCN) actual financial data for accurate valuation outputs.
  • Effortless Scenario Testing: Easily explore various assumptions and analyze their impact on outcomes.
  • Efficiency Booster: Avoid the hassle of constructing intricate valuation models from the ground up.

How It Works

  • 1. Access the Template: Download and open the Excel file containing Lipocine Inc.'s (LPCN) preloaded data.
  • 2. Modify Assumptions: Adjust key parameters such as growth rates, WACC, and capital expenditures.
  • 3. Analyze Results Immediately: The DCF model automatically computes intrinsic value and NPV.
  • 4. Explore Different Scenarios: Evaluate various forecasts to assess different valuation results.
  • 5. Present with Assurance: Share professional valuation insights to bolster your decision-making.

Why Choose This Calculator for Lipocine Inc. (LPCN)?

  • Designed for Experts: A specialized tool utilized by analysts, CFOs, and investment consultants.
  • Accurate Financial Data: Lipocine Inc.'s historical and projected financials are preloaded for precision.
  • Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
  • Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
  • User-Friendly: Step-by-step guidance makes the process straightforward.

Who Should Use Lipocine Inc. (LPCN)?

  • Healthcare Investors: Make informed investment choices with comprehensive analysis of Lipocine's pipeline and market potential.
  • Pharmaceutical Analysts: Streamline your research with detailed reports on Lipocine's drug development progress and financial performance.
  • Consultants: Easily modify presentations or reports to highlight Lipocine's strategic initiatives and market positioning.
  • Biotech Enthusiasts: Enhance your knowledge of biopharmaceutical innovations and their impact on health outcomes through Lipocine's case studies.
  • Educators and Students: Utilize Lipocine as a real-world example in pharmacology and business courses to illustrate industry concepts.

What the Template Contains

  • Pre-Filled DCF Model: Lipocine Inc.'s (LPCN) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Lipocine Inc.'s (LPCN) profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.